Your search returned 3 results.

Results
	1.	The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer. [electronic resource] by Claessens, Anouk K M Timman, Reinier Busschbach, Jan J Bouma, Jeanette M Rademaker-Lakhai, Jeany M Erdkamp, Frans L G Tjan-Heijnen, Vivianne C G Bos, Monique E M M Producer: 20200928 In: Breast cancer research and treatment vol. 179 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer. [electronic resource] by Claessens, Anouk K M Erdkamp, Frans L G Lopez-Yurda, Marta Bouma, Jeanette M Rademaker-Lakhai, Jeany M Honkoop, Aafke H de Graaf, Hiltje Tjan-Heijnen, Vivianne C G Bos, Monique E M M Producer: 20201217 In: Acta oncologica (Stockholm, Sweden) vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG). [electronic resource] by Claessens, Anouk K M Bos, Monique E M M Lopez-Yurda, Marta Bouma, Jeanette M Rademaker-Lakhai, Jeany M Honkoop, Aafke H de Graaf, Hiltje van Druten, Edith van Warmerdam, Laurence J C van der Sangen, Maurice J C Tjan-Heijnen, Vivianne C G Erdkamp, Frans L G Producer: 20190108 In: Breast cancer research and treatment vol. 172 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)